Emerging Opportunities in Pharmaceuticals: Biosimilars

Authors

  • Arnab Chatterjee Oracle Consulting (EMEA), Kolkata

DOI:

https://doi.org/10.33516/maj.v51i12.60-65p

Abstract

No Abstract.

Downloads

Download data is not yet available.

Downloads

Published

2016-12-01

How to Cite

Chatterjee, A. (2016). Emerging Opportunities in Pharmaceuticals: Biosimilars. The Management Accountant Journal, 51(12), 60–65. https://doi.org/10.33516/maj.v51i12.60-65p

Issue

Volume 51, Issue 12, December 2016

Section

Pharmaceuticals
Crossref
Scopus
Google Scholar
Europe PMC

References

Biotechnology Innovation Organization: https://www.bio.org

Frost & Sullivan research

US National Library of Medicine: www.ncbi.nlm.nih.gov

India Brand Equity Foundation: http://www.ibef.org

Department of Pharmaceuticals (Govt. of India)

Deloitte Development LLC: www.deloitte.com/us

Quintiles IMS

Sandoz-Novartis